Larson Financial Group
TNGX icon

Larson Financial Group’s Tango Therapeutics TNGX Stock Holding History

Larson Financial Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.5K Buy
581
+331
+132% +$8.62K ﹤0.01% 2307
2026
Q2 		$7.82K Hold
250
– – ﹤0.01% 2548
2026
Q1 		$5.23K Buy
250
+216
+635% +$3.01K ﹤0.01% 2585
2025
Q4 		$301 Buy
+34
New +$293 ﹤0.01% 3211

Other funds holding TNGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Larson Financial Group's TNGX Position: Q3 2026 in Review

Larson Financial Group increased its Tango Therapeutics (TNGX) stake by 132% in Q3 2026, buying an estimated $8.62K and bringing the position to 581 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

Larson Financial Group first reported a position in TNGX in Q4 2025 and has held it in 4 quarters since. 145 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Larson Financial Group held 581 shares of Tango Therapeutics worth $14.5K as of Q3 2026.
  • Larson Financial Group bought 331 Tango Therapeutics shares in Q3 2026, an estimated $8.62K.
  • Tango Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2307 holding.
  • Larson Financial Group first reported a position in Tango Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 145 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.